Inherent PD ‐ L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis
Thoracic Cancer · 2025
DOI: 10.1111/1759-7714.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Yoon Jin Cha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: B7-H1 Antigen, Lung Neoplasms, Breast Neoplasms, Macrophages, Alveolar. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This study aimed to determine the impact of inherent programmed death‐ligand 1 (PD‐L1)‐expressing alveolar macrophages (AMs) on the combined positive score (CPS) of PD‐L1 (22C3) in metastatic breast cancer in the lungs.
Methods
A total of 87 patients with pulmonary metastases of breast cancer were included in this study. Immunohistochemical staining of various PD‐L1 antibodies was performed. The CPSs and CPSs excluding the number of PD‐L1 positive AMs [CPS(NAM)s] with PD‐L1 (22C3) were determined and compared.
Results
Among 87 enrolled patients, 22 had luminal A breast cancer, 24 had luminal B breast cancer, 13 had HER‐2‐positive breast cancer, and 28 had triple‐negative breast cancer (TNBC). CPSs ≥ 10 was observed only in luminal B (12.5%) and TNBC (35.7%) subtypes ( p < 0.001), whereas CPS(NAM)s ≥ 10 was observed only in TNBC (14.3%) ( p = 0.011). Changes from the CPS‐positive to the CPS(NAM)‐negative status occurred in nine cases (10.3%), with significantly higher proportions being observed in the luminal B (12.5%) and TNBC (21.4%) subtypes ( p = 0.007). Tumors showing changes from the CPS‐positive to the CPS(NAM)‐negative status were larger ( p < 0.001); similar findings were observed in the TNBC subgroup ( p = 0.001).
Conclusion
The inclusion of PD‐L1 expressing AMs leads to differences in CPS positivity, especially in large TNBC subtype tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.
ORCID-Profile: Yoon Jin Cha, Ja Seung Koo
Zitieren
APA
Cha, Y. J., Kim, H. M., & Koo, J. S. (2025). Inherent PD ‐ L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70004
Vancouver
Cha YJ, Kim HM, Koo JS. Inherent PD ‐ L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70004
BibTeX
@article{Cha2025,
author = {Cha, Yoon Jin and Kim, Hye Min and Koo, Ja Seung},
title = {Inherent PD ‐ L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis},
journal = {Thoracic Cancer},
year = {2025},
doi = {10.1111/1759-7714.70004}
}
EUVIMED